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Introduction
Itch is defined as “a stimulation of free nerve endings, usually 
at the junction of the dermis and epidermis of the skin, that 
evokes a desire to scratch.” (Encyclopedia Britannica) Although 
most assume itch to be harmless, chronic itch can cause much 
discomfort and affect quality of life. Pain and itch are obviously 
different to the one experiencing either feeling, but whether 
these sensations are processed differently is not so obvious. 
Since the late nineteenth century when pain was discovered 
to be a real sensation, itch was thought of as just a weaker 
form of pain (Von Frey cited in Handwereker, 2014). Later, sci-
entists found certain unmyelinated C-fibres of the dorsal root 
ganglion that were sensitive specifically to histamine (Schmelz, 
et. al. 1997). Similar histamine sensitive neurons were found in 
lamina I of the spinal cord (Andrew, Craig, 2001). This led to the 
specificity theory for itch, also called the labelled line theory, 
which proposes that different sets of neurons exclusively medi-
ate itch or pain. However, many of the receptors that respond 
to itchy stimuli are also involved in mediating pain and later 
studies show that most of the neurons that respond to itch also 
react to pain producing substances (Shmelz, et.al.2003, Simons, 
2004, Davidson, et. al., 2007, Akiyama, et. al.2009, Akiyama, et.al. 
2010).  So although itch and pain have separate pathways, a lot 
of overlap seems to exist between them.
Methods
This review was written through the critical analysis of clinical 
research papers and peer reviewed journal articles. The papers 
were found in searches on Google Scholar and access was ob-
tained through the Touro College Library.
Discussion
Researchers first thought of itch as a milder form of pain, a 
theory known as the intensity theory. According to this theory, 
pain and itch sensations are mediated by the same neurons; if 
the stimulus is strong, there is a pain sensation, and if the stimu-
lus is weak, an itch sensation (quoted in Patel, Dong, 2010). The 
basis for this theory was that cordotomy, surgical disconnection 
of the spinothalamic tract, leads to loss of both itch and pain 
on the contralateral side of the cut, whereas the perception of 
touch is impaired on the ipsilateral side (Nathan, 1990). This led 
to the theory that itch and pain are conducted along the same 
ascending pathway whereas mechanosensation travels along a 
separate path  (quoted in Handwerker, 2014). However, many 
well-known characteristics of itch and pain don’t seem to fit 
with this theory.  For one, itch can be quite intense and never 
turn into pain, (Tuckett, 1982) and similarly, a painful stimulus 
does not feel like itch when administered at a lower intensi-
ty (Ochoa, Torebjork, 1989). More, the reflexes in response to 
pain and itch are quite different. The pain reflex is withdrawal, 
whereas the itch reflex is scratching. These observations seem 
to suggest that pain and itch have separate neural pathways. 
One of the first steps in the advancement of itch research was 
the discovery of histamine. Histamine is released from mast 
cells and white blood cells, as a response to allergens or inflam-
matory mediators. A “triple response” to histamine was found. 
There is a local reaction, swelling, and also erythema, a flare, 
skin reddening around the affected skin (quoted in Handwerker, 
2014). Histamine could be applied to specific regions and 
therefore allowed for the identification of the neurons which 
responded to it.  
The breakthrough came in 1997, when using the new comput-
er-assisted marking technique in microneurography, one group 
was able to identify histamine-sensitive C-fibers. Previous re-
search had shown that itch had sometimes been induced during 
microstimulation in skin nerves where C-fibers were recorded. 
But most C-fibers identified were insensitive or only weakly 
responsive to histamine. The new technique was able to identify 
even small units that could not be identified with the old meth-
ods.  Researchers identified 56 fibers in the superficial peroneal 
nerve of 52 healthy patients. Units were classified as mechan-
ically and heat-responsive (CMH), heat-responsive (CH), or 
unresponsive to mechanical and heat stimulation (CMiHi). All 
of the fibers were tested by iontophoresis of histamine and the 
subjects rated the itch feeling. After the application of histamine, 
itch was usually felt 30-60 seconds after, reached a maximum 
after 2-3 minutes, and lasted for about 10 minutes. Twenty- 
three of the fifty-six units studied were not at all excited by the 
histamine. Twenty were weakly activated but their discharges 
did not match up with the time response of the subjects. Eight 
of the units (5 CH and 3 CMiHi) showed lasting responses to 
the histamine that coordinated with the time response of the 
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subjects.  These neurons were found to have a much slower 
conduction velocity than the non- histamine responsive neu-
rons, suggesting that these neurons are a class onto themselves. 
The units with histamine responses had a mean velocity of 
.52m/sec., compared to the .9m/sec. of the other units.  The 
slow velocity reflects small axon diameters. Additionally, the 
units were found to have unusually large innervation territories. 
This finding explains the flare that is found after application of 
histamine (Schmelz, et. al. 1997). 
The next study that supported the idea of an itch-specific path-
way was done on cats and found a population of histamine-selec-
tive lamina I spinothalamic tract (STT) neurons. The researchers 
obtained recordings from 190 lamina I STT neurons that had 
distal hind limb fields in the lumbosacral spinal cords of 33 cats. 
After categorizing these neurons into three main classes- noci-
ceptive-specific, thermoreceptive- specific, and polymodal noci-
ceptive- based on response to natural mechanical and thermal 
stimuli, there were 17 neurons left that were mechanically and 
thermally insensitive.  Unlike the mechanically and thermally sen-
sitive neurons, these neurons did not show spontaneous activ-
ity. These neurons were found to have a similar response time 
after histamine application to their innervation area of skin to 
the histamine selective neurons found in the previous study.  The 
conduction velocities of these neurons were slower than the rest 
of the lamina I STT neurons, which is also consistent with the 
findings of the previously mentioned study. In addition, they all 
had large receptive fields, similar to the histamine selective fibers 
in the previous study. These characteristics that differed from the 
rest of the neurons seem to put these neurons into a class of 
their own. Some of the histamine-responsive neurons were test-
ed with mustard oil, which causes a burning sensation, and some 
responded to it. Of those that responded to the mustard oil, 
most had responses that were much weaker than the response 
to histamine. The neuron that had a strong response to the mus-
tard oil had been found to have a weaker response to histamine 
than the rest of the histamine-responsive neurons. Some of the 
histamine- responsive neurons did not respond at all to mustard 
oil, indicating that they are histamine-selective. (One should note, 
however, that the neurons were never tested with capsaicin, an 
algogen) (Andrew, Craig, 2001). This study and the one mentioned 
above both support the “specificity theory,” as it seems like units 
were found that responded specifically to histamine. 
Knowing that histamine is not the only pruritogen, a later study 
tested different pruritogens to see if the histamine-selective 
units would respond to them in accordance with pruritic po-
tency of the pruritogen. They found that many histamine-selec-
tive units responded to the other pruritogens more than the 
non-histamine-selective units. However, they also found that the 
mechano- insensitive, histamine responsive units could also be 
excited by capsaicin and bradykinin, both algogens, albeit with 
a different response pattern than the CMH units. The mecha-
no-responsive units had intense, short-lasting responses to cap-
saicin, whereas the mechano-insensitive units had longer lasting 
responses.  This challenges the specificity theory as the itch 
units were activated by algogens (Shmelz,et.al.2003). Another 
study tested the responsiveness of STT neurons from the ven-
tral posterior lateral nucleus of the thalamus in monkeys to 
different algogens and pruritogens. Neurons were found that 
responded to both histamine and capsaicin, another challenge 
to specificity, this time in the STT. (Simone, 2003) 
As the pathway for itch becomes clearer and more defined, the 
question of how the brain processes the signals from the path-
way as itch rather than pain remains uncertain. 
The Histamine Dependent Pathway
Histamine binds with histamine receptors on free nerve end-
ings. These receptors are classified into four subtypes, 1-4.  In 
order to determine which of the four histamine receptors are 
responsible for the Ca2+ influx into the cell after the applica-
tion of histamine, agonists of the different subtypes were applied 
with the histamine. The only agonist that stopped the calcium 
response was the histamine type-1 receptor (H1R) agonist, me-
pyramine (Nicolson, et.al. 2002). In pharmaceutical attempts to 
alleviate itch the H1R became the major target (Simons, 2004). 
In the mediation of itch, H1R was found to activate phospholi-
pase Cβ 3 (PLCβ3). PLCβ3 is expressed in neurons with histo-
logical markers for unmyelinated, C-fiber nociceptors. PLCβ3 is 
coexpressed with H1R in 90% of H1R neurons, suggesting that 
PLCβ3 may also be involved in the transduction of itch. Indeed, 
PLCβ3-deficient mice showed low Ca2+ release in response to 
histamine application, compared to the regular Ca2+ response 
to application of ATP, capsaicin, UTP, and bradykinin. In vivo 
testing showed that PLCβ3 deficient mice started scratching 
later and scratched less in response to histamine injection than 
wild-type mice. The PLCβ3 deficiency was most noticed when 
the H1R agonist, HTMT, was applied to the PLCβ3-deficient 
mice, and was compared to application of agonists of the other 
histamine receptors. The scratching response to HTMT was al-
most as low as the response to the control, saline injection. This 
indicates that PLCβ3 responds mainly to activity in the H1R 
receptor. Reduced scratching was also found in the response to 
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48/80, a substance that causes degranulation of mast cells and 
therefore the release of histamine  (Han, et.al. 2006).
Activation of PLCβ3 causes increase in intracellular Ca2+ in the 
DRG neurons through the ion channel TRPV1. TRPV1, transient 
receptor potential vanilloid receptor-1, an ion channel, is a re-
ceptor that is found on free nerve endings and allows the action 
potential to occur by allowing Ca2+ into the neuron.  Although 
TRPV1 was previously only known for its role in mediating pain, 
there were clues that it may also be involved in processing itch. 
For one, capsaicin, a major algogen that activates TRPV1, can 
cause itch when applied to the skin surface (Green, Shaffer, 
1993).  In addition, TRPV1 and histamine receptors are found on 
the same subset of neurons )Nicolson, et. al. 2002).  Lastly, when 
high levels of capsaicin are applied to the skin, TPRV1 is desensi-
tized and, interestingly, pruritus is also stopped (quoted in Shim, 
et. al. 2007). Indeed, studies show that TRPV1 has a role in medi-
ating itch. When H1R or TRPV1 alone was transfected to HEK 
293T cells, these cells did not respond to histamine. However, 
H1R and TRPV1 transfected together caused a large current in 
response to histamine application. Further, when capsazapine, 
a TRPV1 antagonist, was applied to the skin before histamine 
application, it caused smaller Ca2+ responses to histamine. In 
addition, TRPV1-deficient mice did not have a large increase 
in intracellular Ca2+ when histamine was applied, in contrast 
to wild-type mice who did. In vivo studies also proved TPRV1’s 
involvement in the mediation of itch. Capsazapine given before 
histamine injection in mice resulted in reduced scratching to 
the histamine. Compared to wild-type mice, TRPV1-deficient 
mice also showed reduced scratching in response to histamine 
injection (Shim, et.al. 2007).  These experiments demonstrate 
that TRPV1 plays a role in the transduction of itch.  
The Histamine Independent Pathway
Although histamine plays a role in allergic itch, histamine is not 
the main pruritic mediator in most diseases of chronic itch 
(Klein, Clark, 1999). The use of H1R antagonists, antihistamines, 
are ineffective in stopping chronic itch (Twycross, et.al. 2003). 
Chronic itch can be caused by the release of pruritogens from 
lymphocytes, mast cells, and eosinophils (Ikoma, et,al, 2006). In 
patients with atopic dermatitis, antihistamines did not suppress 
itch upon degranulation of mast cells. This suggests that there 
are mast cell itch mediators other than histamine (Rukweid, 
et.al. 2000). In addition, one of the regular characteristics of 
histamine induced itch, the flare, is missing in many types of itch 
(Ikoma, et. al. 2005). These findings point to another pathway for 
itch other than the mechano-insensitive C-fibres that mediate 
histamine induced itch. 
Cowhage, the common name for the spicules that cover the 
tropical plant Mucuna pruriens, causes severe itch without a 
flare response (Johanek, et. al. 2007).  It has been found in bio-
chemical studies that mucunain, a proteinase in the cowhage, 
is what makes cowhage itchy (Reddy, et.al. 2008) In a study 
designed to test if histamine and cowhage activate the same 
C-fibres, all CMH units responded to cowhage, and none of the 
CMi, histamine responsive, units did, proving that cowhage and 
histamine do not activate the same fibres (Namer, et.al. 2008). 
Thus, cowhage has been used in many studies to understand 
histamine- independent itch. 
Proteinases, such as mucunain, activate proteinase-activated 
receptors (PARs).  A specific proteinase-activated receptor, 
PAR-2, has been identified on afferent nerve fibers (Steinhoff, 
et. al. 2000). PAR-2 is also activated by trypsin and tryptase. 
Tryptase is released by mast calls and trypsin is expressed in 
the skin (quoted in Shimada, et. al. 2006). The first study that 
found a connection between PAR-2 and itch was done on mice 
and found that PAR-2 played a major role in allergic dermatitis. 
PAR-2 deficiency led to reduced ear swelling.  (Kawagoe, et.al. 
2002) Patients with atopic dermatitis (AD) were found to have 
an increase in PAR-2 signaling, which was seen through higher 
levels of codeine-induced tryptase, PAR-2 expression on kera-
tinocytes, and a greater response to PAR-2 agonist (Steinhoff, 
et.al. 2003). Another study found that itch was induced by PAR-2 
agonist, a peptide, SLIGRL-NH2. When mice were injected with 
SLIGRL-NH2 they started vigorously scratching in levels much 
higher than when injected with saline vehicle. The application 
of an antihistamine, pyrilamine, did not reduce the scratching, 
confirming that PAR-2 is a receptor in non-histaminergic itch 
(Shimada, et.al. 2006).
One of the drugs used to treat malaria is chloroquine. Many 
patients complain about intense itch while taking chloroquine. 
The itch can be so intense that they stop taking the medicine. 
Antihistamines were ineffective in relieving the itch (quot-
ed in Liu, et.al. 2009). Parts of the Mrgpr family (Mas related 
G-protein coupled receptors), a family of G protein-coupled 
receptors (GPCR), have been detected only on small-diameter 
sensory neurons in the DRG and TG. This would make them 
likely to be involved in the sensation of pain or itch. Itch induced 
by chloroquine was reduced in Mrpgr deficient mice, although 
the response to histamine induced itch was not significantly 
reduced in these mice. Further study found that the specific 
Mrgpr receptor for chloroquine was MrgprA3.  BAM-822 was 
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found to excite MrgprC11 (Liu, et.al. 2009).
TRPA1, an ion channel, plays the same role in histamine- inde-
pendent and chronic itch as TRPV1 plays in histamine dependent 
itch. That is, it allows the action potential to occur by allowing 
Ca2+ into the neurons. Researchers found that TRPA1 is greatly 
expressed in subset of TRPV1 positive neurons. Chloroquine 
and BAM-822 were found to activate the subset of TRPV1 
neurons that also expressed TRPA1. Yet, neurons from TRPV1-
deficient mice and neurons treated with capsazapine, a TRPV1 
antagonist, both showed regular Ca2+ signaling in response to 
BAM and chloroquine. There was also no difference in action 
potential firing in response to chloroquine and BAM between 
TRPV1-deficient neurons and wild-type neurons. Thus, it is 
shown that the TRPV1 ion channel is not required for the me-
diation of BAM and chloroquine itch. However, TRPA1-deficient 
neurons had significantly decreased responses to both BAM and 
chloroquine. (As would be expected, they did have normal re-
sponses to histamine.) Further testing showed that the primary 
target for the MrgprA3 and MrgprC11 receptors was TRPA1. 
Interestingly, BAM and chloroquine have different mechanisms 
leading to activation of TRPA1. Thus, TRPA1 is downstream of 
different histamine- independent itch pathways (Wilson, et.al. 
2011). Another study found TRPA1to be a vital mediator in 
chronic itch. Application of AEW (acetone/ether mixture with 
water) to the mouse cheek causes chronic itch-like symp-
toms in mice. It causes dry skin and increases scratching. It 
also causes epidermal thickening, a major symptom of chronic 
itch due to psoriasis in humans. Compared to wild-type mice, 
TRPA1-deficient mice showed significant reduction in scratch-
ing induced by AEW treatment. This is in contrast to TRPV1-
deficient mice who after AEW treatment showed no decrease 
in scratching. Further, injection of TRPA1 inhibitor, HC-030031, 
into cheeck also caused reduction in scratching in AEW treated 
mice. These results show that TRPA1 is required in chronic itch. 
(Wilson, et.al. 2013).
One study used a novel approach to test if there are distinct 
histaminergic and non-histaminergic pathways. Instead of de-
leting certain receptors or neurons, this group used QX-314, 
a sodium channel blocker, to selectively “silence” specific re-
ceptors. When QX-314 was inserted into the mouse along 
with histamine, sodium currents in TRPV1 alone were blocked, 
thus temporarily “silencing” TRPV1. QX-314 inserted along 
with chloroquine had the same effect on TRPA1, silencing it. 
When TRPV1 was silenced, histamine induced scratching was 
stopped, but chloroquine induced scratching was regular, and 
when TRPA1 was silenced, chloroquine induced scratching 
was stopped. This confirmed the separate pathways for itch. 
(Roberson, et.al. 2013)
The above information has shown at least two DRG pathways 
for itch- histaminergic and non-histaminergic. A few other itch 
pathways were found, such as the pathway for β-alanine which 
is unique (Liu, et.al. 2012 b). Some other receptors have been 
found as well, such as toll-like receptor 7 (TLR7) and toll-like 
receptor 3 (TLR3). Although TLR7 knockout mice showed 
normal sensitivity to thermal and mechanical pain and showed 
normal scratching response to histamine-dependent prurito-
gens, scratching response to non-histaminergic pruritogens 
was significantly reduced  (Liu, et.al. 2010). TLR3 knockout mice 
showed reduced scratching response to both histaminergic and 
non-histaminergic stimuli and TLR3 was found to be necessary 
in the development of chronic itch (Liu, et.al. 2012a). Another 
itch mediator found was the cytokine, interleukin-31 (IL-31). 
IL-31 is produced by T-cells and mice generated to overexpress 
it developed intense pruritus. IL-31 protein was fed to adult 
mice and within 3-4 days the mice developed severe pruritus 
(Dillon, et.al. 2004).
The separate histaminergic and non-histaminergic pathways 
continue into the spinal cord. In a study done on monkeys, 57 
dorsal horn, STT neurons were tested for responsiveness to his-
tamine and cowhage. Nineteen responded either to histamine 
or cowhage; none responded to both. This shows a continuation 
of the separate pathways. Interestingly, all pruritogen-responsive 
neurons also responded to capsaicin, further evidence against 
the specificity theory. As pointed out above, the study done on 
STT neurons that suggested the existence of histamine-specif-
ic neurons did not test for response to capsaicin, thus lacking 
evidence that those neurons did not respond to pain stimuli 
(Davidson, et. al., 2007). 
Just like overlap was found in the neurons mediating pain and 
itch in the dorsal root ganglia, overlap was also found in the 
trigeminal ganglia (TG) and the trigeminal subnucleus caudalis 
of mice. Mice TG neurons were tested with different prurito-
gens, i.e. histamine, PAR-2 agonist, and 5-HT, and algogens, i.e. 
capsaicin and AITC. Using calcium imaging it was found that of 
856 TG neurons, 15.4% responded to histamine and 5.8% to 
PAR-2 agonist. Although a small percentage of the pruritogen-
ic neurons only responded to one pruritogen, the majority of 
those pruritogenic neurons responded to AITC or capsaicin as 
well, another finding that is inconsistent with the specificity the-
ory. Consistent with the findings of different histaminergic and 
non-histaminergic pathways, most pruritogenic neurons were 
responsive to only one of the pruritogens. The majority of TG 
neurons that responded to pruritic stimuli were also respon-
sive to algogens  (Akiyama, et. al. 2010). Another study found 
neurons in the superficial dorsal horn that were responsive to 
PAR-2 agonist and 5-HT, yet most were also responsive to algo-
gens (Akiyama, et.al. 2009).
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As can be seen from the information presented above, many 
of the receptors in the itch pathways are also involved in the 
transduction of pain. TRPV1, PAR-2, TRPA1, and the TLRs all 
play roles in mediating pain. It has also been shown that algo-
gens can activate pruritogenic neurons. It seems that there is 
no itch-specificity. However, two neurons have been found that 
seem to be itch-specific GRPR+ neurons and, more recently, 
MrgprA3+ neurons. 
At the spinal level, gastrin-releasing peptide receptor, GRPR, has 
been found to be essential for mediating itch exclusively and 
not pain. GRP is expressed in a subgroup of dorsal root ganglion 
neurons. It is also colocalized with markers for unmyelinated 
fibers. In addition, approximately 80% of GRP+ neurons express 
TRPV1. GRP+ neurons are found only in the lamina I and II 
outer layer in the spinal cord. This data points to a possible in-
volvement of the GRP signaling pathway in itch and pain. GRPR 
mutant mice were tested along with wild-type mice. GRPR 
mutant mice did not show a significantly different response 
from the wild-type mice to heat, pain, or mechanical stimuli. 
The mice were then tested with three different pruritogenic 
agents: 48/80, a PAR-2 agonist (SLIGRL-NH2), and chloroquine. 
After the separate injection of each pruritogen, a scratch count 
was taken from the mice. Although the GRPR mutant mice did 
scratch as a response to the injection, the number of scratches 
was significantly reduced, showing that GRPR mediates itch. To 
test whether activating GRPR at the spinal level would induce 
itch, GRPR agonist, GRP18-27, was intrathecally administered to 
the wild-type mice.  It induced scratching behavior. As expected, 
the scratching response to GRP18-27 was significantly lower 
in GRPR mutant mice. In addition, when GRPR antagonist was 
inserted 10 minutes before the pruritogen in wild-type mice, 
scratching behavior was significantly reduced. Interestingly, the 
antagonist caused a lesser reduction in the effect of compound 
48/80 than it had on PAR-2 agonist and chloroquine. This may be 
because PAR-2 and chloroquine act through a histamine-inde-
pendent pathway, unlike compound 48/80. Since GRPR mutant 
mice showed regular pain responses to mechanical, thermal, 
and pain stimuli, but significantly reduced itch responses to pru-
ritogens, GRPR+ neurons seem to be itch-specific (Sun, Chen, 
2007). However, this does not rule out the possibility that GRPR 
neurons can also respond to pain and in GRPR mutant mice the 
loss of these neurons is compensated for by the other nocicep-
tive neurons and therefore pain is still felt.  
In order for something to be considered completely itch spe-
cific it needs to fulfill three criteria. First and most obvious, the 
neurons must respond to pruritic stimuli. Second, the loss of 
these neurons should only cause a loss of itch, not pain. Last, and 
most vital, only an itch response should be elicited when these 
neurons are specifically activated, not pain. The study done on 
the GRPR mutant mice fulfilled the first two criteria, but did not 
test for the third. 
One group of neurons that was found to fit all the criteria is 
the MrgprA3+ neurons. These neurons only innervate the skin 
and were found to be absent from all other tissues, one clue 
that these neurons may be specific to itch, which is only felt on 
the epidermis.  These neurons were coexpressed with TRPV1. 
They were also found to synapse with GRPR neurons in the 
spinal cord.  These neurons responded to all types of itch other 
than β-alanine. When these MrgprA3+ neurons where ablated 
from a mouse line, the mice still showed regular responses to 
pain stimuli, though response to itch stimuli was greatly re-
duced. Mice have clearly distinct responses to itch and pain and 
therefore it is easy to know what sensation is being felt. Facial 
wiping with the forelimb is the response to pain, and scratching 
with the hindpaw is the response to itch (Shimada, LaMotte, 
2008). (One interesting find was that the itch response to β-al-
anine was regular in MrgprA3+ -ablated mice, confirming that 
the neural pathway for β-alanine is unique.) In order to rule 
out the possibility that MrgprA3+ neurons are not necessary 
in pain response but can still be involved, MrgprA3+ neurons 
were specifically activated to see what response the neuron 
would elicit- pain or itch. The researchers used TRPV1-deficient 
mice and transfected TRPV1 only on the MrgprA3+ neurons. 
When capsaicin, an algogen, was injected into the cheek of these 
mice, the mice responded with scratching. This is in contrast to 
both wild-type mice that responded with wiping and TRPV1-
deficient mice that did not respond at all. Thus it was shown 
that MrgprA3+ neurons coexpressed with TRPV1 elicit an itch 
response, regardless of the stimuli (Han, et. al. 2013). This is the 
first study to prove the existence of itch-specific neurons. No 
matter what the stimulus was, the sensation transmitted by 
those neurons was itch. 
Conclusion
After the two initial studies that seemed to find itch-specific 
neurons, the support for the labelled line theory weakened. As 
seen above, many of the receptors for itch are also involved in 
the transduction of pain. Even more, itch responsive neurons 
in the DRG, TG, and the spinal cord also respond to algogens, 
such as capsaicin. However, with the finding of the MrgprA3+ 
itch-specific neurons, it is possible that the labelled line the-
ory is correct for at least some of itch transduction.  GRPR+ 
may also be part of this itch-specific group that mediates itch 
although further research would be necessary to confirm that. 
The study done on TG neurons also found a small population 
of pruriceptive neurons that only responded to pruritogens. 




Even if itch is mediated through the few pruriceptive-specific 
neurons, it is still possible that the units that respond to both 
pruritogens and algogens also signal itch. Pruriceptive neurons 
are a subset of nociceptive neurons. Some hypotheses are that 
if the brain only receives input from the pruriceptive neurons, 
it processes the sensation as itch. However, if the brain is also 
receiving input from the nociceptive neurons, the brain only 
processes the pain and not the itch. So although those pruricep-
tive neurons are responsive to both pruritogens and algogens if 
there is no activity in the nociceptive-specific neurons when an 
itch stimulus is activating the pruriceptive neurons, itch will be 
felt (quoted in Patel, Dong, 2010). Along the same lines, another 
possibility is that the pain pathway activates mechanisms that in-
hibit itch transduction.  Pain inhibiting itch is a familiar phenom-
enon, as it is well known that scratching relieves itch (Shmelz, 
et.al. 2003). A similar inhibition mechanism was suggested in the 
findings of a recent study. TRPV1 and TRPA1 both respond to 
algogenic stimuli. However, the study found that silencing one of 
them can cause algogens to elicit an itch response, i.e. scratch-
ing. This suggests that there can be inhibitors from the other ion 
channel that do not allow the brain to process the feeling as an 
itch (Roberson, 2013).
A final point for consideration is that most of these studies 
were done on animal models. But pain and itch may be mediat-
ed differently in different animals. Therefore, although research 
done on mice and other animals can give us an idea about the 
pathways in humans, further studies must be done to see how 
these mechanisms work in humans. 
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